Executive Summary
The TechSci Research report on the “Animal Sedative Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028” reveals that the Global Animal Sedative Market reached USD 103.45 million in 2022 and is projected to grow at a CAGR of 6.13% from 2024 to 2028. Key factors driving this growth include the surge in veterinary tourism, increased focus on pain management for animals, and the rising incidence of zoonotic diseases associated with surgical procedures.
Growing Veterinary Tourism and Market Impact
Veterinary Tourism Trends
The increasing popularity of certain countries as destinations for veterinary tourism has a direct impact on the global animal sedative market. Pet owners worldwide seek high-quality and cost-effective veterinary care, creating a demand for sedatives in facilities catering to international clientele.
Pain Management for Animals
The prominence of pain management in veterinary care is boosting the demand for animal sedatives. These sedatives not only calm animals but also provide effective pain relief during various procedures, driving the search for products that balance efficacy and safety.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Animal Sedative Market.” – https://www.techsciresearch.com/report/animal-sedative-market/19183.html
COVID-19 Disruptions and Market Resilience
Initial Pandemic Impact
The animal sedative market faced significant disruption during the initial wave of the COVID-19 pandemic. Lockdowns and social distancing measures led to reduced operations in veterinary hospitals and pharmacies, impacting the supply chain and patient access to care.
Post-Pandemic Recovery
As pandemic restrictions eased, the animal sedative market demonstrated signs of recovery. Increased animal surgeries and the introduction of new veterinary sedative products are expected to drive market growth in the post-pandemic era.
Factors Contributing to Market Expansion
Zoonotic Diseases and Pet Population
The expansion of the animal sedative market is influenced by factors such as the rising incidence of zoonotic diseases associated with surgical procedures, a growing pet population, and increased investment in veterinary product development.
Research and Development Advancements
Research studies comparing the efficacy of veterinary sedative products contribute to market growth. For instance, the use of romifidine and lidocaine in donkeys demonstrated pain relief efficacy, leading to advancements in veterinary sedation techniques.
Strategic Partnerships and Product Launches
Key players’ strategic initiatives, including partnerships and product launches, are significant contributors to market expansion. The acquisition of Jurox by Zoetis in September 2022 exemplifies such strategic moves, enhancing Zoetis’ animal health portfolio and global reach.
Who Will Benefit from This Report?
- Pharmaceutical Companies: Insights into market trends, collaborative opportunities, and regulatory landscapes for informed product development strategies.
- Veterinary Hospitals and Clinics: Understanding evolving dynamics in animal sedative use for improved patient care and procedural planning.
- Investors: Identifying investment opportunities and assessing potential returns in the evolving Animal Sedative Market.
- Research Institutions: Accessing valuable data for furthering research and development in veterinary sedatives and related areas.
- Policy Makers: Utilizing insights to shape regulations, allocate resources, and support initiatives in animal health.
Market Segmentation
Type
Acepromazine is poised to dominate the Global Animal Sedative Market in 2022 and beyond. Its longstanding reputation for efficacy, safety, and cost-effectiveness positions it as a trusted choice among veterinarians globally.
Route of Administration
- Parenteral Route: Dominating in 2022 due to immediate and precise effects, preferred in critical or emergency veterinary situations.
- Oral Alternatives: Anticipated to experience substantial growth, driven by ease of administration, reduced stress on animals, and increased caregiver convenience.
The Global Animal Sedative Market is forecasted for significant growth, fueled by factors like growing veterinary tourism, increased focus on pain management, and advancements in sedative efficacy. Despite challenges like emerging adverse effects and stringent regulations, strategic activities by industry players are anticipated to further drive market expansion. The comprehensive insights in this report make it an indispensable resource for stakeholders navigating the dynamic Animal Sedative Market landscape.
Major companies operating in Global Animal Sedative Market are:
- Zoetis Inc
- Boehringer Ingelheim International GmbH
- Merck & Co., Inc.
- Elanco Animal Health Inc
- Virbac SA
- Dechra Pharmaceuticals PLC
- Orion Corporation
- Vetoquinol SA
Customers can also request for 10% free customization on this report.
“The global animal sedative market is poised for significant transformation in the coming years. The upcoming trends reflect the changing landscape of animal care, driven by the evolving expectations of pet owners, veterinarians, and regulators. As these trends continue to shape the industry, stakeholders in the animal sedative market must remain agile and responsive to meet the evolving needs of animals and their caregivers,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.
“Animal Sedative Market By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine), By Route of Administration (Oral, Parenteral), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Animal Sedative Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Animal Sedative Market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=19183
Recently Published Report –
Viral Vector and Plasmid DNA Manufacturing Market
Contact Techsci Research-
US –
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Germany –
S-01, 2.floor, Subbelrather Straße,
15a Cologne,
Germany 50823
Tel: +49 221 65058833
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com
